Noninvasive ventilation (NIV) is recognized nowadays as the first choice of treatment for COPD exacerbation. Compared with standard medical treatment, it can significantly reduce the intubation rate, hospital stay, nosocomial infection, and, above all, mortality rate.1,2 Physiological studies have shown that the mechanism of action of NIV in this population is the ability to sustain alveolar ve...